Rates of completion of the behavioral task
| Group | Value | 95% CI |
|---|---|---|
| 6 Month Micro Expression Training Task | 5 | |
| 12 Month Micro Expression Training Task | 6 |
Last reviewed · How we verify
Assessing Visual Processing in High Anxiety
NA trial testing Facial Microexpression Training in Anxiety in 23 participants. Completed in 15 March 2024.
| Lead sponsor | University of Massachusetts, Worcester |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 23 |
| Start date | 1 March 2021 |
| Primary completion | 15 March 2024 |
| Estimated completion | 15 March 2024 |
| Sites | 1 location across United States |
University of Massachusetts, Worcester
Adults 18 to 30, any sex, with Anxiety. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Rates of completion of the behavioral task
| Group | Value | 95% CI |
|---|---|---|
| 6 Month Micro Expression Training Task | 5 | |
| 12 Month Micro Expression Training Task | 6 |
High trait anxiety, a stable personality trait, is a risk factor for psychiatric disorders. Individuals with high trait anxiety have difficulty differentiating safety from threat, including visual information like emotional faces. This study aims to characterize visual system function in high trait anxiety. A portion of this study involves an intervention. For the intervention portion, a subset of participants will be asked to return for a lab visit upon completing the first portion of the study (multimodal magnetic resonance imaging (MRI) scan). During this follow up visit, participants will complete a computer task that involves looking at faces and identifying emotions. Participants will complete this task either six months or twelve months after their MRI scan visit. Results from this research have the potential to inform novel therapies that target the visual system in individuals at risk for the development of psychiatric disorders.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04187326.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing